Newsroom

News
Infections with Clostridioides difficile (for short: C. difficile) are often recurrent, because dormant stages of the bacterium persist in the intestine. Thus far, there was no drug that can effectively combat the dormant stages as well. A current One Health study led by the Helmholtz Centre for Infection Research (HZI) and the Friedrich-Loeffler-Institute (FLI) now shows that a natural product called chlorotonil A can do just that. The study was conducted in close cooperation with the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a site of the HZI in collaboration with Saarland University, Greifswald University and the Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures GmbH. The research team hopes that chlorotonil A will be a candidate drug that might significantly reduce the risk of reinfection with C. difficile in the future. The study was published in the scientific journal Cell Host & Microbe.
25.04.2023
Portrait
News
Dr Yannic Bartsch's TWINCORE junior research group "Antiviral Antibody Omics" is being funded as a Helmholtz Young Investigator Group (HYIG). Over the next five years, the immunologist will receive a total of 1.5 million euros, half of which will be funded by the Helmholtz Association and half by the Helmholtz Centre for Infection Research (HZI) in Braunschweig. Bartsch already began his work at TWINCORE in January. He is researching the role of antibody responses in infections.
01.04.2023
Infected lung cell
News
The COVID-19 pandemic has dramatically demonstrated that the development of effective agents against viral pathogens is of great importance for global health. Although effective vaccines are available for many viral diseases, there is an urgent need for new and effective therapeutic treatments. At the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), the team led by Prof Rolf Müller is researching novel active substances for the treatment of infections. In their latest studies, the researchers were able to identify two new natural product families with promising activity against viruses. Their results have now been published in the journal Angewandte Chemie International Edition.
20.03.2023
Blutproben
News
Infection with SARS-CoV-2 leads to severe disease in some people, whereas others do not get ill or only experience mild disease. What causes these differences is not fully understood. It is already known that an overactive innate immune system is causing severe COVID-19 disease, but it is unclear how this is regulated. A team led by Prof Yang Li, Director at the Centre for Individualised Infection Medicine (CiiM) and head of department “Computational Biology for Individualised Medicine” at the Helmholtz Centre for Infection Research (HZI), has come a step closer to answering this question. The researchers addressed the question to what extent the course of disease is genetically or epigenetically regulated. The CiiM is a joint initiative by the HZI and Hannover Medical School (MHH). In addition to Li, the team included other scientists from the HZI and the RESIST cluster of excellence.
23.02.2023
Fluorescence microscopic image of a zebrafish larva in which neutrophil granulocytes
News
In the ImageTox project, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and the CISPA Helmholtz Center for Information Security are pooling their expertise in the fields of drug discovery and artificial intelligence (AI). Using state-of-the-art machine learning methods, the two Saarbrücken institutes aim to make research into the modes of action of new drugs more efficient. The project is an initiative within the Helmholtz Medical Security, Privacy, and AI Research Center (HMSP), which brings together leading experts from the fields of IT security, data privacy and AI, and medicine to solve pressing medical challenges. ImageTox is funded with 200,000 euros from Helmholtz Imaging, an initiative to promote imaging research.
15.02.2023

HZI in the media

Schaufler erforscht am Helmholtz-Institut für One Health (HIOH), einem Standort des Helmholtz-Zentrums für Infektionsforschung ( ...

17.11.2026
|
Management & Krankenhaus

Direktor des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) in Würzburgund Sprecher der Leopoldina-Arbeitsgruppe „RNA- ...

16.11.2026
|
Monitor Versorgungsforschung

13, 2026 | Maren Schubert’s lab at the Helmholtz Center for Infection Research has spent a decade refining an alternative to the field’s

13.11.2026
|
Bio-IT World

Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig erwartet insgesamt einen typischen

12.11.2026
|
Wiesbadener Kurier

... Technischen Universität Braunschweig, Forschungsgruppenleiter am Helmholtz Zentrum für Infektionsforschung.

 

Nach seiner Promotion über ...

09.11.2026
|
Radio38

WDR am 05.11.2026: Vitamine sind lebenswichtig. Viele greifen deshalb zu Kapseln, Pulvern und Brausetabletten, um mit einer Extraportion nachzuhelfen.

 

Das Geschäft boomt: Hersteller versprechen mehr Energie, ein stärkeres Immunsystem, gesünderes Altern und Schutz vor Krankheiten

06.11.2026
|
ARD Mediathek

Jörg Vogel, Direktor des Helmholtz-Instituts für RNA-basierte Infektionsforschung und Sprecher der Leopoldina-Arbeitsgruppe RNA-basierte ...

04.11.2026
|
Tagesschau

... Team der MHH beteiligen sich das Helmholtz-Zentrum für Infektionsforschung, das Fraunhofer-Institut für Toxikologie und ...

04.11.2026
|
Deutsches Ärzteblatt

... leitete er eine Forschungsgruppe am Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI) in Würzburg.

 

Vorbeugen - ...

02.11.2026
|
Management & Krankenhaus

"Trump ist eine Bedrohung für die Demokratie und Freiheit. Eine Rückkehr in die USA ist beruflich keine Option mehr", so Biologin Dr. Elsa Anderson. Forschenden droht in den USA in der zweiten Amtszeit von Donald Trump der Verlust ihrer wissenschaftlichen Freiheit, sie suchen des

02.11.2026
|
arte

... nach dem Saarland benannt.

 

Seit gut drei Jahren läuft das vom Helmholtz-Institut für Pharmazeutische Forschung ...

02.11.2026
|
Tagesschau

... ist Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung (HZI) und Mitglied der Ständigen Impfkommission ...

30.10.2026
|
Focus Online

Register now for the HZI newsletter